69 reports of this reaction
2.0% of all PERMETHRIN reports
#9 most reported adverse reaction
ALOPECIA is the #9 most commonly reported adverse reaction for PERMETHRIN, manufactured by Insight Pharmaceuticals LLC. There are 69 FDA adverse event reports linking PERMETHRIN to ALOPECIA. This represents approximately 2.0% of all 3,377 adverse event reports for this drug.
Patients taking PERMETHRIN who experience alopecia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ALOPECIA is a less commonly reported adverse event for PERMETHRIN, but still significant enough to appear in the safety profile.
In addition to alopecia, the following adverse reactions have been reported for PERMETHRIN:
The following drugs have also been linked to alopecia in FDA adverse event reports:
ALOPECIA has been reported as an adverse event in 69 FDA reports for PERMETHRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ALOPECIA accounts for approximately 2.0% of all adverse event reports for PERMETHRIN, making it a notable side effect.
If you experience alopecia while taking PERMETHRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.